History
2024: Completion of a plant for the production of drugs for the treatment of rheumatic diseases and oncology
In the special economic zone "Dubna" of the Moscow Region, the construction of a new scientific and production pharmaceutical complex of the company "Argumentum Pharma" has been completed. Investments in the project amounted to ₽1,8 billion. This became known in October 2024. The company will specialize in the production of drugs for the treatment of cancer, rheumatic and cardiovascular diseases.
According to Vedomosti, the area of the new plant exceeds 6.5 thousand square meters. meters. At the first stage, the company will be able to produce about 60 million units of drugs per year, many of which are import-substituting.
Deputy Prime Minister - Minister of Investments, Industry and Science of the Moscow Region Yekaterina Zinovieva said that by the end of 2024 the company plans to improve the adjacent territory and interior decoration. In 2025, it is planned to install and adjust equipment. The launch of the first stage of the pharmaceutical complex is expected in 2025, while at least 100 jobs will be created for residents of the Moscow region.
The production program of the enterprise is focused on the production of import-substituting drugs included in the list of vital and essential drugs (vital and essential drugs). The range will include drugs to stabilize blood pressure during surgery, treat hypertension, tachycardia, myocardial infarction, as well as pain syndrome, including for anesthesia during childbirth.
Oleg Levchenko, General Director of Argumentum Pharma, noted that the entire production complex with an area of more than 8 thousand square meters. meters will be built on a plot of 2.3 hectares in accordance with the requirements of international quality standards. The laboratory and production complex will consist of two buildings with "clean rooms," where liquid drugs will be developed and produced in ampoules, vials and pre-filled syringes.[1]
2023: Start of construction of a plant for the production of vital drugs for 1.8 billion rubles
The Argumentum Pharma company has begun construction of an enterprise in the Dubna SEZ near Moscow, which will be engaged in the production of medicines, including those that are included in the list of vital and essential drugs (vital and essential drugs). The total investment in the project exceeds 1.8 billion rubles. The press service of the Ministry of Investment, Industry and Science of the Moscow Region announced this on October 20, 2023.
By this day, the builders erected columns and the frame of the building. It is planned to complete the construction and launch, first of all, a research and production complex with an area of over 6.5 thousand square meters by the end of the second quarter of 2025.
At the enterprise in the SEZ "Dubna," the company will be engaged in the production of medicines that are designed to stabilize blood pressure, treat arrhythmia, tachycardia, myocardial infarction. Analgesics, including long-acting ones, and drugs intended for the treatment of rheumatic and oncological diseases will also be produced here.
It is assumed that at the first stage the company will be able to produce more than 55 million units of drugs per year. The company will create over 100 jobs, with the launch of the second stage, the staff will be increased. The project on the territory of the Dubna SEZ will be implemented with the assistance of the Moscow Region Development Corporation (KRMO).
 | This is a strategically important area of import substitution, "says Vladimir Slipenkin, General Director of the Moscow Region Development Corporation. - The shortage of drugs, especially vital ones, is absolutely unacceptable, and now all the capacities of the pharmacological industry have been accumulated in order to launch new or develop existing production of drugs from the VED list. Analogues of foreign drugs should not be inferior to them in quality and, if possible, be more financially accessible.[2] |  |
2021: Launch of production of vital drugs for 1.5 billion rubles in the SEZ "Dubna"
At the end of July 2021, it became known that the Argumentum Pharma company, in the status of a resident of the Dubna SEZ, will be engaged in the production of sterile finished medicines, including those included in the list of vital and essential drugs. Investments in the project amount to 1.5 billion rubles.
Argumentum Pharma plans to create about 120 new workplaces. The company leases a land plot in the Dubna SEZ with a total area of about 2.3 hectares, on which a laboratory and production complex with a total area of at least 9.2 thousand square meters will be built.
Medicinal products manufactured by the company can be used:
- to stabilize blood pressure during surgical interventions;
- hypertension, tachycardia, myocardial infarction;
- for pain syndrome, including for pain relief during childbirth.
The Ministry of Investment, Industry and Science of the Moscow Region noted that among the company's products there will be analogues of foreign drugs. The goal of the project is the import substitution of foreign analogues with more affordable products of domestic production, which are not inferior to them in quality, the department added.
| | For Argumentum Pharma LLC, all this [preferences from the placement of SEZ production] will significantly reduce costs at the stage of development and introduction into the production of a drug and, as a result, reduce the cost of production, which will lead to lower prices for the country's population for important drugs, - said the Minister of Investment, Industry and Science of the Moscow Region Ekaterina Zinovieva. | |
According to the SPARK-Interfax system, Argumentum Pharma LLC was registered in the Dubna city district in early May 2021 and is 100% owned by entrepreneur Oleg Levchenko. The company specializes in the production of medicinal products and materials used for medical purposes. The authorized capital of the legal entity is 100 thousand rubles.[3]
Notes
- ↑ A plant for the production of drugs for the treatment of rheumatic diseases and oncology was built in the Moscow region
- ↑ Construction of a plant for the production of vital drugs has begun in Dubna
- ↑ In the SEZ in the north-west of the Moscow region, the production of vital and essential drugs will be created
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |